76 related articles for article (PubMed ID: 17392581)
1. Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase.
Mitsuyama K; Tomiyasu N; Takaki K; Masuda J; Yamasaki H; Kuwaki K; Takeda T; Kitazaki S; Tsuruta O; Sata M
Mediators Inflamm; 2006; 2006(6):26875. PubMed ID: 17392581
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and Anti-Inflammatory Activity of Phenolic-Rich Extract from
Tavares EA; Guerra GCB; da Costa Melo NM; Dantas-Medeiros R; da Silva ECS; Andrade AWL; de Souza Araújo DF; da Silva VC; Zanatta AC; de Carvalho TG; de Araújo AA; de Araújo-Júnior RF; Zucolotto SM
Plants (Basel); 2023 Jan; 12(3):. PubMed ID: 36771677
[TBL] [Abstract][Full Text] [Related]
3. An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in
Chua KJ; Ling H; Hwang IY; Lee HL; March JC; Lee YS; Chang MW
ACS Biomater Sci Eng; 2023 Sep; 9(9):5123-5135. PubMed ID: 36399014
[TBL] [Abstract][Full Text] [Related]
4. Mucosal Interleukin-10 depletion in steroid-refractory Crohn's disease patients.
Carrasco A; Tristán E; Fernández-Bañares F; Martín-Cardona A; Aceituno M; Zabana Y; Fluvià L; Hernández JM; Lorén V; Manyé J; Salas A; Andújar X; Loras C; Esteve M
Immun Inflamm Dis; 2022 Oct; 10(10):e710. PubMed ID: 36169258
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases.
Enver A; Ozmeric N; Isler SC; Toruner M; Fidan C; Demirci G; Elgun S; Silva APBD
J Periodontol; 2022 Nov; 93(11):1649-1660. PubMed ID: 35665507
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease biomarkers.
Liu D; Saikam V; Skrada KA; Merlin D; Iyer SS
Med Res Rev; 2022 Sep; 42(5):1856-1887. PubMed ID: 35603998
[TBL] [Abstract][Full Text] [Related]
7.
Wong WY; Chan BD; Sham TT; Lee MM; Chan CO; Chau CT; Mok DK; Kwan YW; Tai WC
Front Nutr; 2022; 9():816836. PubMed ID: 35529468
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects.
Żyła E; Dziendzikowska K; Kamola D; Wilczak J; Sapierzyński R; Harasym J; Gromadzka-Ostrowska J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923129
[TBL] [Abstract][Full Text] [Related]
9. An immune therapy model for effective treatment on inflammatory bowel disease.
Park A; Kim S; Jung IH; Byun JH
PLoS One; 2020; 15(9):e0238918. PubMed ID: 32970698
[TBL] [Abstract][Full Text] [Related]
10. Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine.
Besednova NN; Zaporozhets TS; Kuznetsova TA; Makarenkova ID; Kryzhanovsky SP; Fedyanina LN; Ermakova SP
Mar Drugs; 2020 May; 18(6):. PubMed ID: 32486405
[TBL] [Abstract][Full Text] [Related]
11. Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma-An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer.
Wahl RU; Leijs M; Araujo A; Rübben A
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188047
[TBL] [Abstract][Full Text] [Related]
12. Low Serum Interleukin-10 Is an Independent Predictive Factor for the Risk of Second Event in Clinically Isolated Syndromes.
Wei Y; Chang H; Feng H; Li X; Zhang X; Yin L
Front Neurol; 2019; 10():604. PubMed ID: 31244763
[No Abstract] [Full Text] [Related]
13. Homoectoine Protects Against Colitis by Preventing a Claudin Switch in Epithelial Tight Junctions.
Castro-Ochoa KF; Vargas-Robles H; Chánez-Paredes S; Felipe-López A; Cabrera-Silva RI; Shibayama M; Betanzos A; Nava P; Galinski EA; Schnoor M
Dig Dis Sci; 2019 Feb; 64(2):409-420. PubMed ID: 30269272
[TBL] [Abstract][Full Text] [Related]
14. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis.
Cardoso A; Gil Castro A; Martins AC; Carriche GM; Murigneux V; Castro I; Cumano A; Vieira P; Saraiva M
Front Immunol; 2018; 9():400. PubMed ID: 29545807
[TBL] [Abstract][Full Text] [Related]
15. Immunological pathogenesis of inflammatory bowel disease.
Lee SH; Kwon JE; Cho ML
Intest Res; 2018 Jan; 16(1):26-42. PubMed ID: 29422795
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.
Korolkova OY; Myers JN; Pellom ST; Wang L; M'Koma AE
Clin Med Insights Gastroenterol; 2015; 8():29-44. PubMed ID: 26078592
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-17 and IL-6 increased accompany with TGF-β and IL-13 respectively in ulcerative colitis patients.
Feng JS; Yang Z; Zhu YZ; Liu Z; Guo CC; Zheng XB
Int J Clin Exp Med; 2014; 7(12):5498-504. PubMed ID: 25664061
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Saxena A; Khosraviani S; Noel S; Mohan D; Donner T; Hamad AR
Cytokine; 2015 Jul; 74(1):27-34. PubMed ID: 25481648
[TBL] [Abstract][Full Text] [Related]
19. Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease.
Shadnoush M; Shaker Hosseini R; Mehrabi Y; Delpisheh A; Alipoor E; Faghfoori Z; Mohammadpour N; Zaringhalam Moghadam J
Iran J Pharm Res; 2013; 12(4):929-36. PubMed ID: 24523774
[TBL] [Abstract][Full Text] [Related]
20. Why interleukin-10 supplementation does not work in Crohn's disease patients.
Marlow GJ; van Gent D; Ferguson LR
World J Gastroenterol; 2013 Jul; 19(25):3931-41. PubMed ID: 23840137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
